Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17–24 years old
Intramuscular cabotegravir for long-acting injectable HIV pre-exposure prophylaxis (ie, LAI-
PrEP) was approved by the US FDA in 2021. We sought to explore LAI-PrEP decision …
PrEP) was approved by the US FDA in 2021. We sought to explore LAI-PrEP decision …
Tenofovir diphosphate in dried blood spots is strongly associated with viral suppression in individuals with human immunodeficiency virus infections
JR Castillo-Mancilla, M Morrow… - Clinical Infectious …, 2019 - academic.oup.com
Background Although tenofovir diphosphate (TFV-DP) in dried blood spots (DBS) is a
predictor of adherence and pre-exposure prophylaxis efficacy, its utility in human …
predictor of adherence and pre-exposure prophylaxis efficacy, its utility in human …
Metabolic effects of preexposure prophylaxis with coformulated tenofovir disoproxil fumarate and emtricitabine
DV Glidden, K Mulligan, V McMahan… - Clinical Infectious …, 2018 - academic.oup.com
Background Antiretroviral drugs have been associated with changes in lipids, fat mass and
dat distribution. Tenofovir disoproxil fumarate (TDF) has been shown to have a more …
dat distribution. Tenofovir disoproxil fumarate (TDF) has been shown to have a more …
Preferences for injectable PrEP among young US cisgender men and transgender women and men who have sex with men
KB Biello, S Hosek, MT Drucker, M Belzer… - Archives of sexual …, 2018 - Springer
Young men who have sex with men account for approximately 20% of incident HIV
infections in the US Antiretroviral pre-exposure prophylaxis (PrEP) administered as a daily …
infections in the US Antiretroviral pre-exposure prophylaxis (PrEP) administered as a daily …
DOT diary: developing a novel mobile app using artificial intelligence and an electronic sexual diary to measure and support PrEP adherence among young men who …
AY Liu, ND Laborde, K Coleman, E Vittinghoff… - AIDS and Behavior, 2021 - Springer
Young men who have sex with men (YMSM) are highly vulnerable to HIV. While pre-
exposure prophylaxis (PrEP) has demonstrated effectiveness, adherence has been low …
exposure prophylaxis (PrEP) has demonstrated effectiveness, adherence has been low …
Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention
SE Rowan, RR Patel, JA Schneider, DK Smith - The lancet HIV, 2021 - thelancet.com
Pre-exposure prophylaxis (PrEP) is highly effective in reducing HIV transmission but
remains underutilised globally. Same-day PrEP prescribing and medication provision is an …
remains underutilised globally. Same-day PrEP prescribing and medication provision is an …
Comparison of measures of adherence to human immunodeficiency virus preexposure prophylaxis among adolescent and young men who have sex with men in the …
CA Koss, SG Hosek, P Bacchetti… - Clinical Infectious …, 2018 - academic.oup.com
Background Young men-who-have-sex-with-men (MSM) are disproportionately impacted by
human immunodeficiency virus (HIV). Preexposure prophylaxis (PrEP) could reduce HIV …
human immunodeficiency virus (HIV). Preexposure prophylaxis (PrEP) could reduce HIV …
Multi-level interventions to promote oral pre-exposure prophylaxis use among adolescent girls and young women: a review of recent research
E Irungu, N Khoza, J Velloza - Current HIV/AIDS Reports, 2021 - Springer
Purpose of review This review summarizes interventions to promote HIV pre-exposure
prophylaxis (PrEP) use among adolescent girls and young women (AGYW) in HIV endemic …
prophylaxis (PrEP) use among adolescent girls and young women (AGYW) in HIV endemic …
Pre-exposure prophylaxis (PrEP) awareness, attitudes and uptake willingness among young people: gender differences and associated factors in two South African …
ABSTRACT Background: Pre-exposure prophylaxis (PrEP) for HIV prevention is safe and
effective in reducing HIV incidence. However, more evidence of PrEP knowledge …
effective in reducing HIV incidence. However, more evidence of PrEP knowledge …
Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure …
AR Bazzi, ML Drainoni, DL Biancarelli, JJ Hartman… - BMC public health, 2019 - Springer
Background People who inject drugs (PWID) are at increased risk for HIV acquisition and
could benefit from antiretroviral pre-exposure prophylaxis (PrEP). However, PrEP has been …
could benefit from antiretroviral pre-exposure prophylaxis (PrEP). However, PrEP has been …